Please login to the form below

Video: Immuno-oncology therapies

Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research. 

http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/


6th July 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

RP Investigates - Virtual Q&A session:
Living with Lupus
Research Partnership
Webcast:
Demand assessment
Research Partnership
White paper:
Are we prepared for the influx of CAR-Ts?
Research Partnership
New syndicated patient report -
Living with Lupus US
Research Partnership
Video:
Emotion AI
Research Partnership
Report:
Mexico’s drug market access landscape shake-up: What does it mean for pharma?
Research Partnership